News – Page 489 – Endpoints News

Four months after first intranasal flunks influenza test, Revelation's second-gen asset misses on efficacy

3 years ago

Bavarian Nordic nabs EU approval for monkeypox vaccine as WHO declares global health emergency

3 years ago

Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks

3 years ago

On a roll, AstraZeneca flags looming approvals for three big drug franchises

3 years ago

With AAV alternative and DNA writing tech, a new hub-and-spoke startup wants to ‘democratize’ gene therapies

3 years ago

Churn in FDA’s inspection unit; Roche’s changing of the guard; Illumina on defense; NASH believer finds new ...

3 years ago

Bavarian Nordic's monkeypox vaccine wins positive opinion from EMA committee

3 years ago

'We will continue to fight': Contraceptive companies remain hopeful after House passes bill

3 years ago

EMA joins regulatory coalition in calling for RWE to be integrated into regulatory decisions

3 years ago

Super-speedy cancer drug reviews: FDA unveils new draft guidance to help sponsors apply

3 years ago

Idorsia adds Olympic gold medalist and insomnia patient Lindsey Vonn to its celebrity spokesperson roster

3 years ago

Lonza posts double-digit growth in H1 thanks to strong pharma demand

3 years ago

Unlikely duo leads bipartisan Senate bill to expand Right to Try into MDMA and psilocybin

3 years ago

Updated: Gritstone goes the credit facility route, securing $80M to keep clinical efforts running

3 years ago

Sosei Heptares partners with a UK-based cancer research organization to bring its drug to trial

3 years ago

J&J's BCMA/CD3 bispecific nabs a conditional EMA nod, jumping in front of FDA

3 years ago

VistaGen faces another fail as anxiety drug flops a PhIII study — shares crater

3 years ago

Exclusive: Turnover tsunami at FDA's pharma inspections office puts the backlog in sharp focus

3 years ago

Vertex wins 'breakthrough' nod for non-opioid pain drug; After US withdrawal, EMA restricts Clovis' Rubraca

3 years ago

Astellas gathers scattered cell and gene therapy, BD units in new $70M South San Francisco hub

3 years ago

Biden to tap Harvard surgeon, clinical trials expert as NCI director

3 years ago

Ex-Moderna commercial leader lands at Celsion as CEO; Schwan song: Changing of the guard at Roche to take effect next ...

3 years ago

OrbiMed-backed Silverback, three months after hacking the pipeline, reverse-merges with small allergy biotech

3 years ago

VMLY&R Health adds new managing director and creative head, with aims to match pharmas' patient focus

3 years ago

First page Previous page 486 487 488489490 491 492 Next page Last page